Arrowhead Pharmaceuticals, Inc.
ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF

Last updated:

Abstract:

Integrin ligands having serum stability and affinity for .alpha.v.beta.6 integrins are described. Compositions comprising .alpha.v.beta.6 integrin ligands having serum stability and having affinity for .alpha.v.beta.6 integrins and methods of using them are also described.

Status:
Application
Type:

Utility

Filling date:

14 Oct 2021

Issue date:

27 Jan 2022